LSALT peptide

Overview

LSALT peptide is a selective DPEP-1 inhibitor with selectivity over DPEP2 / 3 . LSALT peptide inhibits neutrophil and monocyte/macrophage recruitment, inflammation, and tissue injury. LSALT peptide reduces kidney damage, improves survival in murine sepsis and endotoxemia models. LSALT peptide can be used for the research of COVID-19, sepsis, acute respiratory distress syndrome, and acute kidney injury.

Application

Products | Products > Disease Areas > Infection | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Renal Disease | Products > Disease Areas > SARS-CoV-2 Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Infection | Products > Research Areas > Endocrinology | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-P11879
• CAS No.: 2567713-50-0
• Molecular Formula: C85H136N20O21
• Molecular Weight: 1774.11
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source